Abstract
Sickle cell disease is a group of inherited single-gene autosomal recessive disorders caused by the ‘sickle’ gene, which affects haemoglobin structure. SCD has its origins in sub-Saharan Africa and the Middle East; hence, it is most prevalent in individuals of African descent as well as in the Caribbean, Middle East, parts of India and the Mediterranean and South and Central America. Owing to population migration, SCD is now of increasing importance worldwide [1].
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Stuart MJ, Nagel RL. Sickle cell disease. Lancet. 2004;364:1343–60.
Weatherall D, Akinyanju O, Fucharoen S, Olivieri N, Musgrove P, et al. Inherited disorders of haemoglobin. In: Jamison DT, Breman JG, Measham AR, Alleye G, Claeson M, Evans DB, editors. Disease control priorities in developing countries. 2nd ed. Washington, DC/New York: The World Bank/Oxford University Press; 2006. p. 663–80.
Powars DR, Sandhu M, Niland-Weiss J, Johnson C, Bruce S, Manning PR. Pregnancy in sickle cell disease. Obstet Gynecol. 1986;67:217–28.
Villers MS, Jamison MG, De Castro LM, James AH. Morbidity associated with sickle cell disease in pregnancy. Am J Obstet Gynecol. 2008;199:125.e1–5.
Clarkson JG. The ocular manifestations of sickle-cell disease: a prevalence and natural history study. Trans Am Ophthalmol Soc. 1992;90:481–504.
Sickle Cell Society. Standards for the clinical care of adults with sickle cell disease in the UK. London: Sickle Cell Society; 2008.
Rees DC, Olujohungbe AD, Parker NE, Stephens AD, Telfer P, Wright J, British Committee for Standards in Haematology General Haematology Task Force by the Sickle Cell Working Party. Guidelines for the management of acute painful crisis in sickle cell disease. Br J Haematol. 2003;120:744–52.
National Confidential Enquiry into Patient Outcome and Death. A sickle crisis? A report of the national confidential enquiry into patient outcome and death. London: NCEPOD; 2008.
Howard RJ, Tuck SM, Pearson TC. Pregnancy in sickle cell disease in the UK: results of a multicentre survey of the effect of prophylactic blood transfusion on maternal and fetal outcome. Br J Obstet Gynaecol. 1995;102:947–51.
Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91:288–94.
Smith-Whitley K, Zhao H, Hodinka RL, Kwiatkowski J, Cecil R, Cecil T, et al. Epidemiology of human parvovirus B19 in children with sickle cell disease. Blood. 2004;103:422–7.
Styles LA, Abboud M, Larkin S, Lo M, Kuypers FA. Transfusion prevents acute chest syndrome predicted by elevated secretory phospholipase A2. Br J Haematol. 2007;136:343–4.
Tuck SM, Studd JW, White JM. Sickle cell disease in pregnancy complicated by anti-U antibody. Case report. Br J Obstet Gynaecol. 1982;89:91–2.
Anyaegbunam A, Morel MI, Merkatz IR. Antepartum fetal surveillance tests during sickle cell crisis. Am J Obstet Gynecol. 1991;165:1081–3.
Legardy JK, Curtis KM. Progestogen-only contraceptive use among women with sickle cell anemia: a systematic review. Contraception. 2006;73:195–204.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer India
About this chapter
Cite this chapter
Gupta, S., Shobhane, H.J. (2016). Management of Sickle Cell Crisis in Pregnancy. In: Gandhi, A., Malhotra, N., Malhotra, J., Gupta, N., Bora, N. (eds) Principles of Critical Care in Obstetrics. Springer, New Delhi. https://doi.org/10.1007/978-81-322-2686-4_16
Download citation
DOI: https://doi.org/10.1007/978-81-322-2686-4_16
Published:
Publisher Name: Springer, New Delhi
Print ISBN: 978-81-322-2684-0
Online ISBN: 978-81-322-2686-4
eBook Packages: MedicineMedicine (R0)